首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
HUMAN T-CELL HYBRIDOMAS SECRETING INTERLEUKIN-2 (IL-2)
被引:0
作者
:
FOON, K
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
FOON, K
[
1
]
ROSSIO, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
ROSSIO, J
[
1
]
SCHROFF, R
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
SCHROFF, R
[
1
]
ABRAMS, P
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
ABRAMS, P
[
1
]
RAGER, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
RAGER, H
[
1
]
CLARKE, G
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
CLARKE, G
[
1
]
PICKERAL, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
PICKERAL, S
[
1
]
FIDLER, I
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
FIDLER, I
[
1
]
机构
:
[1]
NCI,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701
来源
:
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
1983年
/ 24卷
/ MAR期
关键词
:
D O I
:
暂无
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:220 / 220
页数:1
相关论文
未找到相关数据
未找到相关数据